Cargando…

Biomarkers for Diagnosis, Prognosis and Response to Immunotherapy in Melanoma

SIMPLE SUMMARY: Cutaneous Melanoma is a form of skin cancer characterized by an elevated mutational load that favors high spread to distant organs and resistance to therapies. The identification of biomarkers, able to dissect normal and pathogenic biological processes and response to therapeutic int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puglisi, Rossella, Bellenghi, Maria, Pontecorvi, Giada, Pallante, Giulia, Carè, Alessandra, Mattia, Gianfranco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228007/ https://www.ncbi.nlm.nih.gov/pubmed/34207514 http://dx.doi.org/10.3390/cancers13122875

Ejemplares similares

Sex and Gender Disparities in Melanoma
por: Bellenghi, Maria, et al.
Publicado: (2020)

Different Susceptibilities of Human Melanoma Cell Lines to G2/M Blockage and Cell Death Activation in Response to the Estrogen Receptor β agonist LY500307
por: Pontecorvi, Giada, et al.
Publicado: (2022)

SCD5 restored expression favors differentiation and epithelial-mesenchymal reversion in advanced melanoma
por: Puglisi, Rossella, et al.
Publicado: (2018)

On exosome functional role in cancer: miR-494 complex regulation in melanoma cells and corresponding exosomes
por: Bellenghi, Maria, et al.
Publicado: (2019)

A Sex Perspective in Neurodegenerative Diseases: microRNAs as Possible Peripheral Biomarkers
por: Piscopo, Paola, et al.
Publicado: (2021)

Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies
por: Mattia, Gianfranco, et al.
Publicado: (2018)

Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma
por: Felicetti, Federica, et al.
Publicado: (2016)

The Sex-Related Interplay between TME and Cancer: On the Critical Role of Estrogen, MicroRNAs and Autophagy
por: Matarrese, Paola, et al.
Publicado: (2021)

Find the Flame: Predictive Biomarkers for Immunotherapy in Melanoma
por: Garutti, Mattia, et al.
Publicado: (2021)

Non-genomic Effects of Estrogen on Cell Homeostasis and Remodeling With Special Focus on Cardiac Ischemia/Reperfusion Injury
por: Puglisi, Rossella, et al.
Publicado: (2019)

The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway
por: Errico, M Cristina, et al.
Publicado: (2013)

Joint action of miR‐126 and MAPK/PI3K inhibitors against metastatic melanoma
por: Pedini, Francesca, et al.
Publicado: (2019)

AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression
por: Felli, N, et al.
Publicado: (2016)

BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers
por: Castellani, Giorgia, et al.
Publicado: (2023)

CDK4/6 Inhibitors in Melanoma: A Comprehensive Review
por: Garutti, Mattia, et al.
Publicado: (2021)

“To Anticipate”: Neoadjuvant Therapy in Melanoma with a Focus on Predictive Biomarkers
por: Garutti, Mattia, et al.
Publicado: (2020)

Sex disparity in cancer: roles of microRNAs and related functional players
por: Carè, Alessandra, et al.
Publicado: (2018)

FLG Is a Potential Biomarker of Prognosis and Immunotherapy in Skin Cutaneous Melanoma
por: Wu, Shaobo, et al.
Publicado: (2022)

The Role of Biomarkers in the Diagnosis and Prognosis of Different Stages of Melanoma
por: Nwafor, Jane N, et al.
Publicado: (2023)

Insights and Strategies of Melanoma Immunotherapy: Predictive Biomarkers of Response and Resistance and Strategies to Improve Response Rates
por: Seyhan, Attila A., et al.
Publicado: (2022)

Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers
por: Spiliopoulou, Pavlina, et al.
Publicado: (2023)

Immune infiltrates impact on the prediction of prognosis and response to immunotherapy of melanoma patients
por: Vasaturo, Angela, et al.
Publicado: (2015)

Consistent Stool Metagenomic Biomarkers Associated with the Response To Melanoma Immunotherapy
por: Olekhnovich, Evgenii I., et al.
Publicado: (2023)

Autoantibodies Specific to ERα are Involved in Tamoxifen Resistance in Hormone Receptor Positive Breast Cancer
por: Maselli, Angela, et al.
Publicado: (2019)

Melanoma Immunotherapy: Next-Generation Biomarkers
por: Hogan, Sabrina A., et al.
Publicado: (2018)

Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
por: Piñero, Federico, et al.
Publicado: (2020)

Circulating MicroRNAs as Quantitative Biomarkers for Diagnosis and Prognosis of Uveal Melanoma
por: Zhou, Wen-Da, et al.
Publicado: (2022)

Immune Cell Networks Uncover Candidate Biomarkers of Melanoma Immunotherapy Response
por: Vo, Duong H. T., et al.
Publicado: (2022)

Inflammation markers in cutaneous melanoma - edgy biomarkers for prognosis
por: Neagu, Monica, et al.
Publicado: (2015)

Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanoma
por: Mattia, Gianfranco, et al.
Publicado: (2011)

Targeting NK Cells to Enhance Melanoma Response to Immunotherapies
por: Lee, Hansol, et al.
Publicado: (2021)

Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma
por: Nyakas, M., et al.
Publicado: (2019)

Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?
por: Rossi, Ernesto, et al.
Publicado: (2019)

Gut Mesenchymal Stromal Cells in Immunity
por: Messina, Valeria, et al.
Publicado: (2017)

Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects
por: Deacon, Dekker C., et al.
Publicado: (2021)

Chronic Isolation Stress Affects Central Neuroendocrine Signaling Leading to a Metabolically Active Microenvironment in a Mouse Model of Breast Cancer
por: Berry, Alessandra, et al.
Publicado: (2021)

Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma
por: Xue, Ling, et al.
Publicado: (2021)

Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to Immunotherapy
por: Xu, Ziqian, et al.
Publicado: (2021)

A combined aging and immune prognostic signature predict prognosis and responsiveness to immunotherapy in melanoma
por: Lv, Wenchang, et al.
Publicado: (2022)

Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer
por: Gianni, Caterina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q7e7nvcfa0u53k6hgq7u89pr42